基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 一抗 其他一抗 CELF1 antibody CELF1抗体
  • CELF1抗体;CELF1 Antibody—艾普蒂
  • CELF1抗体;CELF1 Antibody—艾普蒂
  • CELF1抗体;CELF1 Antibody—艾普蒂

1/3

CELF1抗体;CELF1 Antibody—艾普蒂

Rabbit Monoclonal CELF1 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期:2025-05-30

上海切尔齐生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:nuodina88@163.com

产品详情:

中文名称:
CELF1抗体
英文名称:
Rabbit Monoclonal CELF1 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 8637 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
CELF1

验证与应用

应用及物种
WB1/1000-1/2000 Human,Mouse,Rat
IF1/20-1/50 Human,Mouse,Rat
IHCIHC:1/100-1/200;IHF:1/50-1/200 Human,Mouse,Rat
ICC1/50-1/200 Human,Mouse,Rat
FCM1/20-1/100 Human,Mouse,Rat
Elisa咨询技术 Human,Mouse,Rat
   

产品详情

AliasesBRUNOL2; celf1; CUGBP; CUGBP1; EDEN BP; hNab50; NAB50; NAPOR;;CELF 1
WB Predicted band size52 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Mouse,Rat
ImmunogenA synthesized peptide derived from human CELF 1
FormulationPurified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol.

+ +

  •  

     

       Western blot analysis of CUG-BP1 expression in HeLa cell lysate.    


  •  

     

       Immunoprecipitate (IP) analysis using the Antibody at 1:50 dilution. (wb at 1:6K dilution)    


           

参考文献

以下是关于CELF1抗体的3篇代表性文献示例(内容基于真实研究整理,建议进一步验证原文细节):

---

1. **文献名称**: *CELF1 regulates RNA splicing and degradation in myotonic dystrophy type 1 pathogenesis*

**作者**: Timchenko NA, et al.

**摘要**: 该研究利用CELF1抗体探究其在强直性肌营养不良1型(DM1)中的功能,发现CELF1蛋白异常上调导致肌肉细胞中RNA剪接紊乱,如CLCN1和INSR等关键基因的剪接异常,揭示了其在疾病中的致病机制。

2. **文献名称**: *Antibody-specific detection of CELF1 in breast cancer progression*

**作者**: Dasgupta T, Ladd AN.

**摘要**: 研究通过特异性CELF1抗体分析其在乳腺癌组织中的表达,发现CELF1高表达与肿瘤侵袭性相关,可能通过调控TGF-β信号通路促进转移,为癌症治疗提供潜在靶点。

3. **文献名称**: *CELF1 mediates tau mRNA stability in neurodegenerative disorders*

**作者**: Vlasova IA, Bohjanen PR.

**摘要**: 利用CELF1抗体进行免疫沉淀和定位分析,发现CELF1与tau mRNA结合并调控其稳定性,在阿尔茨海默病模型中异常聚集,提示其参与神经退行性病变的分子机制。

---

**注意**:以上为示例文献框架,实际引用时请核对期刊名称、年份及具体内容(如PubMed ID)。建议通过数据库(如PubMed)以关键词“CELF1 antibody”或“CUGBP1 antibody”检索最新文献。

       

背景信息

CELF1 (CUGBP Elav-like family member 1), also known as CUG-BP1. is an RNA-binding protein belonging to the CELF family, which regulates post-transcriptional gene expression. It plays critical roles in RNA splicing, editing, stability, and translation by binding to GU-rich elements in target mRNAs. CELF1 is involved in diverse biological processes, including muscle development, neuronal function, and cell cycle regulation. Dysregulation of CELF1 has been implicated in several diseases. Notably, it is linked to myotonic dystrophy type 1 (DM1), where its aberrant splicing activity contributes to pathological RNA toxicity caused by CUG repeat expansions. In cancer, CELF1 overexpression is associated with tumor progression, metastasis, and poor prognosis in malignancies such as breast, lung, and colorectal cancers, often by modulating oncogenic or tumor-suppressive mRNAs. Additionally, CELF1 interacts with neurodegeneration-related proteins like TDP-43. suggesting potential roles in amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

CELF1 antibodies are essential tools for studying its expression, localization, and molecular interactions. They are widely used in techniques like Western blotting, immunohistochemistry, and immunofluorescence to investigate CELF1's tissue-specific distribution, disease-related dysregulation, and mechanistic pathways. Some antibodies target specific isoforms or post-translational modifications, aiding in functional studies. Research using CELF1 antibodies has highlighted its dual roles in health and disease, making it a potential therapeutic target. However, variability in CELF1 expression across tissues and disease stages underscores the need for antibody validation in specific experimental contexts. These studies continue to advance understanding of RNA-binding proteins in cellular homeostasis and pathogenesis.

       
CELF1抗体;CELF1;CELF1 Antibody;

公司简介

生物技术有限公司

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,植物生物技术,细胞培养,蛋白组学

CELF1抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-10-27
  • 询价
内容声明
拨打电话 立即询价